Autopsy report · NCT02858843

The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia

“We were unable to enroll eligible subjects for the study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Cystic Fibrosis; Diabetes

Interventions

lumacaftor-ivacaftor

Participants

1

Trials that died the same way

• Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer
  “Study was unable to recruit subjects meeting the study requirements.” (88% match in meaning)
• A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
  “Unable to recruit and enroll eligible subjects.” (83% match in meaning)
• Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
  “The study was withdrawn due to not being able to recruit subjects.” (80% match in meaning)
• Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI
  “Study did not enroll any subjects.” (80% match in meaning)
• Augmented Reality Heads-up Display to Improve Ultrasound Guided IV Access
  “Unable to enroll subjects.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.